Price $40.87 |
Market Cap
584.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.11
|
P/S
4.4
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
50.0
|
Op. Cash Flow
13.1K
|
FCF
0.8
|
|
Op. Margin
-21.70%
|
Net Margin
-18.40%
|
ROE
-8.40%
|
ROI
-8.70%
|
|
ROA
-5.90%
|
EPS Growth
-187.00%
|
Current Ratio
4.8
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| AEterna Zentaris Inc. (USA) (AEZS) | $0.88 | - | - | 133.3M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $3.04 | - | - | 45.2M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $64.44 | - | 3.10% | 141.03B | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $5.90 | - | - | 2.02B | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $10.75 | - | - | 12.5B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
